Table 1.
Clinical demographics and outcomes of dogs enrolled in the STING clinical trial.
| Dog identifier | 1 | 2 | 3 | 4 | 5 |
| Breed | French bulldog | French bulldog | Cane Corso mastiff | American pit bull terrier | French bulldog |
| Gender/neuter status | MN | MN | FI | FN | MN |
| Age at onset of signs (years) | 9 | 9 | 4 | 10 | 5 |
| Presenting sign | Seizures | Seizures | Seizures | Seizures | Seizures |
| Duration of signs at first treatment | 4 months | 1 month | 6 months | 2 months | 1 month |
| Anatomic location of tumor | Left forebrain | Left forebrain | Right forebrain | Right forebrain | Right forebrain |
| Tumor type/grade | GBM/grade 4 | Small-cell GBM/grade 4 | No tissue | Small-cell GBM/grade 4 | GBM/grade 4 |
| Outcome | Euthanized (progressive disease) | Deceased (aspiration pneumonia) | Euthanized (progressive disease) | Euthanized (progressive disease) | Deceased (loss of cerebral perfusion) |
Abbreviations: F, female; GBM, glioblastoma; I = intact; M, male; N, neutered.